Atherosclerosis. Pathogenesis, classification and functional significance;Atherosklerose. Formale Pathogenese, Klassifikation und funktionelle Bedeutung

Pathologe

Volumn 18, Issue 3, 1997, Pages 218-227

  Brasen J H ^a   Niendorf, A ^a,b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b Gemeinschaftspraxis F Pathologie   (Germany)

Author keywords

atherosclerosis; classification; complication; morphology

Indexed keywords

ATHEROSCLEROSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; REVIEW;

ARTERIAL OCCLUSIVE DISEASES; ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; PROGNOSIS; RISK FACTORS; TUNICA INTIMA;

EID: 0030918440     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002920050209     Document Type: Review

References (74)

1. Alderman EL, Corley SD, Fisher LD, Chaitman BR, Faxon DP, Foster ED, Killip T, Sosa JA, Bourassa MG and the CASS participating investigators and staff (1993) Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the coronary artery surgery study (CASS). Am J Coll Cardiol 22:1141-1154
2. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V (1988) Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 12:56-62
3. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ (1995) Atherosclerosis: basic mechanisms. Oxidation, inflammation and genetics. Circulation 91:2488-2496
4. Blankenhorn DH, Azen SP, Kramsch DM, Mack WJ, Cashin-Hemphill L, Hodis HN, De Boer LW, Mahrer PR, Masteller MJ, Vailas LI et al. (1993) Coronary angiography changes with lovastatin therapy. The monitored atherosclerosis regression study (MARS). The MARS research group. Ann Intern Med 119:969
5. Braesen JH, Beisiegel U, Niendorf A (1995) Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits. Virchows Archiv 426:179-188
6. Brown BG, Zhao XQ, Sacco DE, Albers JJ (1993) Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 87:1781-1791
7. Brown BG, Zhao X-G, Poulin D, Albers JJ (1995) Regression of atherosclerosis. Does it occur and does it have clinical meaning? Eur Heart J 16 [Suppl E]:2-5
8. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM (1995) Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 91:2125-2131
9. Carlos TM, Harlan JM (1994) Leucocyte-endothelial adhesion molecules. Blood 84:2068-2101
10. Clarkson TB, Bond MG, Bullock BC, Marzetta CA (1981) A study of atherosclerosis regression in Macaca mulatta. IV. Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dI. Exp Mol Pathol 34:345-368
11. Constantinides P (1966) Plaque fissures in human coronary thrombosis. J Atheroscler Res 6:1-17
12. Danchin N (1993) Is myocardial revascularisation for tight coronary stenoses always necessary? Lancet 342:224-225
13. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J (1993) Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69:377-381
14. Davies MJ, Gordon JL, Gearing AJH, Pigott R, Woolf N, Katz D, Kyriakopoulos A (1993) The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 171:223-229
15. DeFranco A, Tuzcu EM, Brenner S, Nissen SE (1996) Interventional applications of coronary intravascular ultrasound, angioscopy, and doppler flow. In: Fuster V, Ross R, Topol EJ (eds) Atherosclerosis and coronary artery disease. Lippincott-Raven, Philadelphia, pp 1451-1472
16. Demer LL, Watson KE, Boström K (1994) Mechanisms of calcification in atherosclerosis. Trends Cardiovasc Med 4:45-49
17. Doherty TM, Detrano RC (1994) Coronary arterial calcification as an active process: a new perspective on an old problem. Calcif Tissue Int 54:224-230
18. Falk E (1983) Plaque rupture with severe preexisting stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 50:127-134
19. Falk E (1989) Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol 63:114E-120E
20. Falk E (1992) Why do plaques rupture? Circulation 86 [Suppl III]:III-30-III-42
21. Falk E, Shah PK, Fuster V (1995) Coronary paque disruption. Circulation 92:657-671
22. Falk E, Fernández-Ortiz A (1995) Role of thrombosis in atherosclerosis and its complications. Am J Cardiol 75:58-IIB
23. Faruqi RM, DiCorleto PE (1993) Mechanisms of monocyte recruitment and accumulation. Br Heart J 69 [Suppl]:S19-S29
24. Forrester JS, Litvack F, Grundfest W, Hickey A (1987) A perspective of coronary disease seen through the arteries of living man. Circulation 75 505-513
25. Frink RJ (1994) Chronic ulcerated plaques: new insights into the pathogenesis of acute coronary disease. J Invas Cardiol 6:173-185
26. Furberg CD, Byington RP, Crouse JR, Espeland MA (1994) Pravastatin, lipids and major coronary events. Am J Cardiol 73:1133-1134
27. Fuster V, Badimon L, Badimon JJ, Chesebro JH (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326:242-250, 310-318
28. Fuster V, Badimon JJ (1995) Regression or stabilization of atherosclerosis means regression or stabilization of what we don't see in the arteriogram. Eur Heart J 16 [Suppl4]:6-12
29. Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503
30. Gertz SD, Roberts WC (1990) Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol 66:1368-1372
31. Giroud D, Li JM, Urban P, Meier B, Rutishauser W (1992) Relation of the site of acute myocardial infarction to the most severe coronary arterial stensosis at prior angiography. Am J Cardiol 69:729-732
32. Hansson GK (1993) Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J 69 [Suppl]:S38-S-41
33. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry K, Hembry R, Murphy G, Humphries S (1991) Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 88:8154-8158
34. Hessler JR, Morel DW, Lewis LJ, Chisolm GM (1983) Lipoprotein oxidation and lipoprotein in duced cytotoxicity. Arteriosclerosis 3:215-222
35. Johnson-Tidey RR, McGregor JL, Taylor PR, Poston RN (1994) Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. Am J Pathol 144:952-961
36. Kjekshus JK (1986) Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 57:43F-49F
37. Kragel AH, Reddy SG, Wittes JT, Roberts WC (1989) Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation 80:1747-1756
38. Kragel AH, Reddy SG, Wittes JT, Roberts WC (1990) Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest. Am J Cardiol 66:562-567
39. Lendon CL, Davies MJ, Born GVR, Richardson PD (1991) Atherosclerotic plaques caps are locally weakened when macrophage density is increased. Atherosclerosis 87:87-90
40. Levine GN, Keaney JF, Vita JA (1995) Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med 332:512-521
41. Little WC, Constantinscu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, Santamore WP (1988) Can coronary angiography predict the site of subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78 1157-1166
42. Lundberg G (1985) Chemical composition and physical state of lipid deposits in atherosclerosis. Atherosclerosis 56:93-110
43. MAAS Investigators (1994) Effect of simvastatin on coronary atheroma: the multicentre antiatheroma study (MAAS). Lancet 344:633-638
44. Mclsaac Al, Thomas JD, Topol EJ (1993) Toward the quiescient coronary plaque. J Am Coll Cardiol 22:1228-1241
45. Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, Kurita A, Nakamura H, Ambrose JA (1992) Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med 326 287-291
46. Nabel EG, Nabel GJ (1996) Gene transfer. In: Fuster V, Ross R, Topol EJ (Eds) Atherosclerosis and coronary heart disease Lippincott-Raven, Philadelphia, pp 739-756
47. Nobuyoshi M, Tanaka M, Nosaka H, Kimura T, Yokoi H, Hamasaki N, Kim K, Shindo T, Kimura K (1991) Progression of coronary atherosclerosis: is coronary spasm related to progression? J Am Coll Cardiol 18:904-910
48. Pearson TA, Marx HJ (1993) The rapid reduction in cardiac events with lipid-lowering therapy: mechanisms and implications. Am J Cardiol 72 1072
49. Pitt B, Mancini GBJ, Ellis SG, Rosman HS, McGovern ME (1994) Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC 1). JACC 131A, abstract 739-2
50. Pravastatin Multinational Study Group for Cardiac Risk Patients (1993) Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dI) plus two additional risk factors. Am J Cardiol 72:1031-1037
51. Rabbani LE, Loscalzo J (1994) Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque. Atherosclerosis 105:1-7
52. Rekhter MD, Gordon D (1994) Does platelet-derived growth factor-A chain stimulate proliferation of arterial mesenchymal cells in human atherosclerotic plaques? Circ Res 75:410-417
53. Richardson PD, Davies MJ, Born GVR (1989) Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 2 941-944
54. Rosenschein U, Ellis SG, Yakubov SJ, Haudenschild CC, Dick RJ, Topol EJ (1992) Histopathologk correlates of coronary lesion angiographic morphology: lessons from a directional atherectomy experience. Coron Art Dis 3:953-61
55. Ross R (1986) The pathogenesis of atherosclerosis - an update. N Engl J Med 314:488-500
56. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
57. Sasahara M, Raines EW, Chait A, Carew TE, Steinberg D, Wahl PW, Ross R (1994) Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation? J Clin Invest 94:155-164
58. Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389
59. Shah PK, Falk E, Badimon JJ, Levy G, Fernandez-Ortiz A, Fallon J, Fuster V (1993) Human monocytederived macrophages express collagenase and induce collagen breakdown in atherosclerotic fibrous caps: implications for plaque rupture. Circulation 88 [Suppl I]:I-254, Abstract
60. Small DM (1988) Progression and regression of atherosclerotic lesions: insights from lipid physical biochemistry. Arteriosclerosis 8:103-129
61. Stary HC (1992) Composition and classification of human atherosclerotic lesions. Virchows Archiv [A] 421:277-290
62. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the committee on vascular lesions of the council on atherosclerosis, American Heart Association. Arteriosclerosis Thromb 14:840-856
63. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924
64. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA (1990) Regulation of differential properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 10:966-990
65. Tracy RE, Devaney K, Kissling G (1989) Characteristics of the plaque under a coronary thrombus. Virchows Arch [A] 405 411-427
66. van der Wal AC, Becker AE, van der Loos CM, Das PK (1994) Site of initimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36-44
67. Wissler RW, Vesselinovitch D (1990) Can atherosclerotic plaques regress? Anatomic and biochemical evidence from non-human animal models. Am J Cardiol 65:33-40
68. Witztum JL (1994) The oxidation hypothesis of atherosclerosis. Lancet 344:793-795
69. World Health Organization Technical Report Series (1958) The classification of atherosclerotic lesions. Report of a study group. WHO Tech Rep Ser 143:1-20
70. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84:1086-1095
71. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D (1991) Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88:5252-5256
72. Yiä-Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal E, Särkiojy T, Witztum J, Steinberg D (1991) Gene expression in macrophage-rich human atherosclerotic lesions. 15-Lipoxygenase and acetyl low-density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 87:1146-1152
73. Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27:335-371
74. Zhang Y, Cliff WJ, Schoefl GI, Higgins G (1993) Plasma protein insudation as an index of early coronary atherogenesis. Am J Pathol 143:496-506